Finance

Lists
STAA:NASDAQ
STAAR Surgical Co
$26.39
-1.46%
(-0.39) 1D
$26.10
-1.10% (-0.29)
After hours
Closed: Nov 13, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for STAA...
Open
$26.85
High
$26.90
Low
$26.16
Mkt. cap
1.32B
Avg. vol.
735.77K
Volume
370.19K
P/E ratio
395.95
52-wk high
$35.87
52-wk low
$15.58
EPS
$0.07
Beta
1.22
Shares outstanding
50.20M
No. of employees
921
Open
$26.85
High
$26.90
Low
$26.16
Mkt. cap
1.32B
Avg. vol.
735.77K
Volume
370.19K
P/E ratio
395.95
52-wk high
$35.87
52-wk low
$15.58
EPS
$0.07
Beta
1.22
Shares outstanding
50.20M
No. of employees
921
News stories
From web sources and news partners
About STAAR Surgical Co
CEO-
Employees921
Founded1982
HeadquartersMonrovia, California, United States
SectorHealth Care
IndustryMedical device
Websitestaar.com
Analyst ratings
Based on 3 analysts giving stock ratings to STAA in the past 3 months
Buy
Buy
2
Hold
1
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for STAA in the last 3 months.
Highest
Current $26.39
$34.00 (+28.84%)
Average
$29.67 (+12.43%)
Lowest
$23.00 (-12.85%)
Analyst
Recommendation
Action
Price target
Projected
Date
John Young CFA
Canaccord Genuity
Buy
Maintained
$32.00
+21.3%
11/04/2026
Thomas Stephan
Stifel Nicolaus
Buy
Maintained
$34.00
+28.8%
11/05/2026
Young Li
Jefferies
Hold
Maintained
$23.00
-12.8%
09/22/2026
David Saxon
Needham
Hold
Maintained
-
-
08/13/2026
Adam Maeder
Piper Sandler
Hold
Reiterated
$33.00
+25%
08/13/2026
Simran Kaur
Wells Fargo
Hold
Reiterated
$25.00
-5.3%
08/13/2026
Unknown Analyst
UBS
Sell
Initiated
$20.00
-24.2%
07/28/2026
Patrick Wood
UBS
Sell
Initiated
$20.00
-24.2%
07/28/2026
Michael Piccolo
Wedbush
Buy
Reiterated
$40.00
+51.6%
07/20/2026
Ryan Zimmerman
BTIG
Hold
Maintained
-
-
07/16/2026
Anthony Petrone
Mizuho Securities
Hold
Maintained
$27.00
+2.3%
05/14/2026
Unknown Analyst
Wedbush
Hold
Maintained
$26.00
-1.5%
04/09/2026
Unknown Analyst
Stephens
Hold
Maintained
$28.00
+6.1%
03/04/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Jan 2026
Apr 2026
Jul 2026
Oct 2026
Revenue
57.80M
93.52M
93.54M
83.41M
Cost of goods sold
14.06M
24.66M
23.81M
24.28M
Cost of revenue
14.06M
24.66M
23.81M
24.28M
Research and development expenses
9.24M
9.92M
9.94M
10.46M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
45.40M
41.45M
49.60M
43.13M
Operating expense
54.65M
51.38M
59.54M
53.59M
Total operating expenses
68.71M
76.04M
83.35M
77.87M
Operating income
-10.91M
17.48M
10.18M
5.54M
Other non operating income
1.62M
366.00K
313.00K
306.00K
EBT including unusual items
-20.65M
8.22M
11.02M
6.98M
EBT excluding unusual items
-8.75M
17.64M
11.02M
6.98M
Income tax expense
-2.34M
3.01M
2.97M
1.40M
Effective tax rate
11.35%
36.65%
26.90%
20.13%
Other operating expenses
-
-
-
-
Net income
-18.31M
5.21M
8.06M
5.58M
Net profit margin
-31.68%
5.57%
8.61%
6.68%
Earnings per share
0.01
0.29
0.25
0.19
Interest and investment income
1.07M
907.00K
939.00K
1.18M
Interest expense
-
-
-
-
Net interest expenses
1.07M
907.00K
939.00K
1.18M
Depreciation and amortization charges
-
-
-
-
EBITDA
-8.90M
19.59M
12.57M
7.98M
Gain or loss from assets sale
-1.41M
-
1.00K
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps